Business Segments Edwards Lifesciences Corporation
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.35 USD | -0.17% |
|
-0.27% | -1.06% |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Medical Products | 4.39B | 5.23B | 5.38B | 6B | 5.44B | |||||
Total Assets | 7.24B | 8.5B | 8.29B | 9.36B | 13.06B | |||||
Interest Expense | -15.8M | -18.4M | -19.2M | -17.6M | -19.8M | |||||
Income Tax Expense | 93.3M | 199M | 246M | 199M | 152M | |||||
CAPEX | -407M | -330M | -265M | -253M | -252M | |||||
EBT | 917M | 1.7B | 1.77B | 1.6B | 1.55B | |||||
Gross Profit | 3.31B | 3.98B | 4.3B | 4.62B | 4.32B | |||||
D&A | 107M | 135M | 140M | 145M | 155M | |||||
Operating Income | 898M | 1.69B | 1.75B | 1.53B | 1.38B | |||||
Net Income | 823M | 1.5B | 1.52B | 1.4B | 4.17B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 2.52B | 2.96B | 3.13B | 3.51B | 3.21B | |||||
Total Assets | 1.08B | 1.2B | 1.19B | 1.27B | 1.25B | |||||
Operating Income | 1.73B | 2.05B | 2.13B | 2.31B | 2.16B | |||||
Europe | 974M | 1.19B | 1.17B | 1.33B | 1.32B | |||||
Total Assets | 193M | 198M | 192M | 196M | - | |||||
Operating Income | 479M | 569M | 652M | 710M | 725M | |||||
Rest of World | 436M | 550M | 601M | 709M | 572M | |||||
Total Assets | 311M | 336M | 332M | 354M | 535M | |||||
Operating Income | 150M | 185M | 248M | 310M | 243M | |||||
Japan | 460M | 529M | 474M | 452M | 340M | |||||
Total Assets | 20.4M | 19.7M | 13.2M | 23.8M | - | |||||
Operating Income | 286M | 348M | 377M | 259M | 213M | |||||
Operating Income | -1.36B | -1.61B | -1.71B | -1.92B | - |
- Stock Market
- Equities
- EW Stock
- Financials Edwards Lifesciences Corporation
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















